Company: BLRX
Filing Date: 2025-01-07
Form Type: 424B5
Source: 0001178913-25-000045
Chunk: 24

Company: BioLineRx Ltd.
Filing Date: 2025-01-07
Form: 424B5
Chunk 24
---
 to the pro forma adjustments described above                            |     |     |  0.12 |   |     |   |      |
| Pro forma net tangible book value per ADSe as of September 30, 2024                                                              |     |     |       |   |     |   | 0.06 |
| Increase in net tangible book value per ADS attributable to investors purchasing ADSs and accompanying warrants in this offering |     |     |  0.05 |   |     |   |      |
| Pro forma as adjusted net tangible book value per ADS as of September 30, 2024                                                   |     |     |       |   |     |   | 0.11 |
| Dilution per ADS to investors purchasing the ADSs and accompanying warrants in this offering                                     |     |     |       |   |     | $ | 0.09 |

S - 12 The above table is based on 1,199,859,190 ordinary shares, represented by 79,990,613 ADSs outstanding as of September 30, 2024 and excludes as of such date:

| • | 61,822,395 ordinary shares, represented by 4,121,493 ADSs issued in the November 2024 Registered Direct Offering; |

| • | 85,145,940 ordinary shares, represented by 5,676,396 ADSs issued in January 2025 through its “at-the-market” equity offering program with H.C. Wainwright & Co., LLC, as sales agent; |

| • | 300,829,719 ordinary shares, represented by 20,055,315 ADSs, issuable upon the exercise of outstanding warrants, at a weighted average exercise price of $0.08 per share (or $1.13 per ADS); |

| • | 118,411,755 ordinary shares, represented by 7,894,117 ADSs, issuable upon the exercise of outstanding options under our Amended and Restated 2003 Share Incentive Plan, or the Share Incentive Plan, at a weighted average exercise price of 
 $0.11 per share (or $1.71 per ADS);                                                                                                                                                                                                          |

| • | 32,431,095 ordinary shares, represented by 2,162,073 ADSs, issuable upon the vesting of restricted stock units and performance stock units under our Share Incentive Plan, with exercise prices ranging from $0 to $0.03